12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Epas1
|
ENSMUSG00000024140.9 | endothelial PAS domain protein 1 |
Bcl3
|
ENSMUSG00000053175.10 | B cell leukemia/lymphoma 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Epas1 | mm10_v2_chr17_+_86753900_86753914 | -0.78 | 4.8e-03 | Click! |
Bcl3 | mm10_v2_chr7_-_19822698_19822776 | 0.05 | 8.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_3357012 | 4.49 |
ENSMUST00000180719.1
|
Gm26520
|
predicted gene, 26520 |
chr1_-_158958367 | 3.46 |
ENSMUST00000159861.2
|
Pappa2
|
pappalysin 2 |
chr13_+_89540636 | 2.80 |
ENSMUST00000022108.7
|
Hapln1
|
hyaluronan and proteoglycan link protein 1 |
chr11_+_34314757 | 2.73 |
ENSMUST00000165963.1
ENSMUST00000093192.3 |
Fam196b
|
family with sequence similarity 196, member B |
chr2_+_169632996 | 2.69 |
ENSMUST00000109159.2
|
Tshz2
|
teashirt zinc finger family member 2 |
chrX_-_38252398 | 2.53 |
ENSMUST00000089056.3
ENSMUST00000089054.4 ENSMUST00000066498.7 |
Tmem255a
|
transmembrane protein 255A |
chr3_-_97297778 | 2.41 |
ENSMUST00000181368.1
|
Gm17608
|
predicted gene, 17608 |
chr6_-_129233969 | 2.38 |
ENSMUST00000181517.1
|
2310001H17Rik
|
RIKEN cDNA 2310001H17 gene |
chr19_+_16956110 | 2.27 |
ENSMUST00000087689.4
|
Prune2
|
prune homolog 2 (Drosophila) |
chr1_-_174921813 | 2.03 |
ENSMUST00000055294.3
|
Grem2
|
gremlin 2 homolog, cysteine knot superfamily (Xenopus laevis) |
chr8_+_82863351 | 1.98 |
ENSMUST00000078525.5
|
Rnf150
|
ring finger protein 150 |
chr2_+_174760619 | 1.77 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr5_+_102481546 | 1.67 |
ENSMUST00000112854.1
|
Arhgap24
|
Rho GTPase activating protein 24 |
chrX_+_164506320 | 1.63 |
ENSMUST00000033756.2
|
Asb9
|
ankyrin repeat and SOCS box-containing 9 |
chr6_-_129385497 | 1.58 |
ENSMUST00000032261.6
|
Clec12b
|
C-type lectin domain family 12, member B |
chr2_+_135659625 | 1.47 |
ENSMUST00000134310.1
|
Plcb4
|
phospholipase C, beta 4 |
chr13_-_92131494 | 1.46 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr5_-_30461902 | 1.45 |
ENSMUST00000133509.1
ENSMUST00000074171.6 ENSMUST00000114747.2 ENSMUST00000144125.1 |
Otof
|
otoferlin |
chr1_+_75507077 | 1.36 |
ENSMUST00000037330.4
|
Inha
|
inhibin alpha |
chr11_+_61022560 | 1.36 |
ENSMUST00000089184.4
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr6_-_112946754 | 1.35 |
ENSMUST00000113169.2
|
Srgap3
|
SLIT-ROBO Rho GTPase activating protein 3 |
chr2_+_105127200 | 1.34 |
ENSMUST00000139585.1
|
Wt1
|
Wilms tumor 1 homolog |
chrX_-_162159717 | 1.30 |
ENSMUST00000087085.3
|
Nhs
|
Nance-Horan syndrome (human) |
chr19_+_8664005 | 1.29 |
ENSMUST00000035444.3
ENSMUST00000163785.1 |
Chrm1
|
cholinergic receptor, muscarinic 1, CNS |
chr7_-_100863373 | 1.25 |
ENSMUST00000142885.1
ENSMUST00000008462.3 |
Relt
|
RELT tumor necrosis factor receptor |
chr11_+_71750680 | 1.21 |
ENSMUST00000021168.7
|
Wscd1
|
WSC domain containing 1 |
chr2_+_106695594 | 1.19 |
ENSMUST00000016530.7
|
Mpped2
|
metallophosphoesterase domain containing 2 |
chr1_+_109982710 | 1.17 |
ENSMUST00000112701.1
|
Cdh7
|
cadherin 7, type 2 |
chr6_+_47244359 | 1.17 |
ENSMUST00000060839.6
|
Cntnap2
|
contactin associated protein-like 2 |
chr7_-_141117772 | 1.16 |
ENSMUST00000067836.7
|
Ano9
|
anoctamin 9 |
chr4_-_132144486 | 1.16 |
ENSMUST00000056336.1
|
Oprd1
|
opioid receptor, delta 1 |
chr19_+_23758819 | 1.12 |
ENSMUST00000025830.7
|
Apba1
|
amyloid beta (A4) precursor protein binding, family A, member 1 |
chr15_-_68363139 | 1.10 |
ENSMUST00000175699.1
|
Gm20732
|
predicted gene 20732 |
chr5_+_35757875 | 1.09 |
ENSMUST00000101280.3
ENSMUST00000054598.5 ENSMUST00000114205.1 ENSMUST00000114206.2 |
Ablim2
|
actin-binding LIM protein 2 |
chr6_-_112947246 | 1.06 |
ENSMUST00000088373.4
|
Srgap3
|
SLIT-ROBO Rho GTPase activating protein 3 |
chr7_-_100656953 | 1.01 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr6_-_124768330 | 1.00 |
ENSMUST00000135626.1
|
Eno2
|
enolase 2, gamma neuronal |
chr3_+_105452326 | 0.97 |
ENSMUST00000098761.3
|
Kcnd3
|
potassium voltage-gated channel, Shal-related family, member 3 |
chr16_-_52454074 | 0.96 |
ENSMUST00000023312.7
|
Alcam
|
activated leukocyte cell adhesion molecule |
chr3_-_152668135 | 0.94 |
ENSMUST00000045262.6
|
Ak5
|
adenylate kinase 5 |
chr4_-_134018829 | 0.93 |
ENSMUST00000051674.2
|
Lin28a
|
lin-28 homolog A (C. elegans) |
chr4_-_42661893 | 0.92 |
ENSMUST00000108006.3
|
Il11ra2
|
interleukin 11 receptor, alpha chain 2 |
chr17_-_28560704 | 0.90 |
ENSMUST00000114785.1
ENSMUST00000025062.3 |
Clps
|
colipase, pancreatic |
chr2_-_63184253 | 0.90 |
ENSMUST00000075052.3
ENSMUST00000112454.1 |
Kcnh7
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
chr5_+_64970069 | 0.90 |
ENSMUST00000031080.8
|
Fam114a1
|
family with sequence similarity 114, member A1 |
chr2_+_119351222 | 0.89 |
ENSMUST00000028780.3
|
Chac1
|
ChaC, cation transport regulator 1 |
chr1_+_195017399 | 0.89 |
ENSMUST00000181273.1
|
A330023F24Rik
|
RIKEN cDNA A330023F24 gene |
chr10_-_5550636 | 0.88 |
ENSMUST00000041639.5
|
Syne1
|
spectrin repeat containing, nuclear envelope 1 |
chr4_-_20778527 | 0.88 |
ENSMUST00000119374.1
|
Nkain3
|
Na+/K+ transporting ATPase interacting 3 |
chrX_+_142681398 | 0.87 |
ENSMUST00000112889.1
ENSMUST00000101198.2 ENSMUST00000112891.1 ENSMUST00000087333.2 |
Tmem164
|
transmembrane protein 164 |
chr7_+_121392266 | 0.87 |
ENSMUST00000084628.3
|
Hs3st2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
chr15_-_3583146 | 0.86 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr15_+_57694651 | 0.84 |
ENSMUST00000096430.4
|
Zhx2
|
zinc fingers and homeoboxes 2 |
chr1_-_90969644 | 0.83 |
ENSMUST00000130042.1
ENSMUST00000027529.5 |
Rab17
|
RAB17, member RAS oncogene family |
chrX_+_140664908 | 0.81 |
ENSMUST00000112990.1
ENSMUST00000112988.1 |
Mid2
|
midline 2 |
chr11_+_95010277 | 0.81 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr11_-_69695521 | 0.79 |
ENSMUST00000181261.1
|
Tnfsf12
|
tumor necrosis factor (ligand) superfamily, member 12 |
chr12_-_86892540 | 0.74 |
ENSMUST00000181290.1
|
Gm26698
|
predicted gene, 26698 |
chrX_+_140664565 | 0.74 |
ENSMUST00000128809.1
|
Mid2
|
midline 2 |
chr4_+_49059256 | 0.73 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr12_-_67221221 | 0.73 |
ENSMUST00000178814.1
ENSMUST00000179345.2 |
Mdga2
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2 MAM domain-containing glycosylphosphatidylinositol anchor protein 2 |
chr17_-_29237759 | 0.71 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chr4_-_126325641 | 0.70 |
ENSMUST00000131113.1
|
Tekt2
|
tektin 2 |
chr18_+_49979427 | 0.70 |
ENSMUST00000148989.2
|
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr17_+_48932368 | 0.70 |
ENSMUST00000046254.2
|
Lrfn2
|
leucine rich repeat and fibronectin type III domain containing 2 |
chr3_+_51661167 | 0.70 |
ENSMUST00000099106.3
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chr18_+_49979514 | 0.70 |
ENSMUST00000179937.1
|
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr4_+_137862237 | 0.69 |
ENSMUST00000102518.3
|
Ece1
|
endothelin converting enzyme 1 |
chr8_+_62951361 | 0.68 |
ENSMUST00000119068.1
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr11_+_114851814 | 0.67 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr11_-_101785252 | 0.65 |
ENSMUST00000164750.1
ENSMUST00000107176.1 ENSMUST00000017868.6 |
Etv4
|
ets variant gene 4 (E1A enhancer binding protein, E1AF) |
chr13_+_58807884 | 0.64 |
ENSMUST00000079828.5
|
Ntrk2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr6_+_71199827 | 0.64 |
ENSMUST00000067492.7
|
Fabp1
|
fatty acid binding protein 1, liver |
chr8_-_3694167 | 0.63 |
ENSMUST00000005678.4
|
Fcer2a
|
Fc receptor, IgE, low affinity II, alpha polypeptide |
chr10_+_17796256 | 0.63 |
ENSMUST00000037964.6
|
Txlnb
|
taxilin beta |
chr2_+_4300462 | 0.63 |
ENSMUST00000175669.1
|
Frmd4a
|
FERM domain containing 4A |
chr4_+_32983417 | 0.63 |
ENSMUST00000084747.5
|
Rragd
|
Ras-related GTP binding D |
chr6_+_40628824 | 0.62 |
ENSMUST00000071535.6
|
Mgam
|
maltase-glucoamylase |
chr5_+_81021583 | 0.62 |
ENSMUST00000121707.1
|
Lphn3
|
latrophilin 3 |
chr11_-_105944128 | 0.62 |
ENSMUST00000184086.1
|
Cyb561
|
cytochrome b-561 |
chr11_-_105944412 | 0.60 |
ENSMUST00000019734.4
ENSMUST00000184269.1 ENSMUST00000150563.1 |
Cyb561
|
cytochrome b-561 |
chr17_-_34882094 | 0.60 |
ENSMUST00000025230.8
|
C2
|
complement component 2 (within H-2S) |
chr4_-_126325672 | 0.59 |
ENSMUST00000102616.1
|
Tekt2
|
tektin 2 |
chr2_+_105126505 | 0.59 |
ENSMUST00000143043.1
|
Wt1
|
Wilms tumor 1 homolog |
chr8_+_68880491 | 0.58 |
ENSMUST00000015712.8
|
Lpl
|
lipoprotein lipase |
chrX_-_64276937 | 0.58 |
ENSMUST00000114679.1
ENSMUST00000069926.7 |
Slitrk4
|
SLIT and NTRK-like family, member 4 |
chr14_-_60177482 | 0.58 |
ENSMUST00000140924.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr6_+_124493101 | 0.57 |
ENSMUST00000049124.9
|
C1rl
|
complement component 1, r subcomponent-like |
chr16_-_59553970 | 0.57 |
ENSMUST00000139989.1
|
Crybg3
|
beta-gamma crystallin domain containing 3 |
chr18_-_80713062 | 0.57 |
ENSMUST00000170905.1
ENSMUST00000078049.4 |
Nfatc1
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
chr15_-_3583191 | 0.56 |
ENSMUST00000069451.4
|
Ghr
|
growth hormone receptor |
chr11_+_3983636 | 0.56 |
ENSMUST00000078757.1
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
chr5_-_92505518 | 0.56 |
ENSMUST00000031377.7
|
Scarb2
|
scavenger receptor class B, member 2 |
chr8_-_33731793 | 0.56 |
ENSMUST00000079376.5
|
1700104B16Rik
|
RIKEN cDNA 1700104B16 gene |
chr17_-_57078490 | 0.55 |
ENSMUST00000011623.7
|
Dennd1c
|
DENN/MADD domain containing 1C |
chr3_+_134236483 | 0.55 |
ENSMUST00000181904.1
ENSMUST00000053048.9 |
Cxxc4
|
CXXC finger 4 |
chr8_+_23153271 | 0.55 |
ENSMUST00000071588.6
|
Nkx6-3
|
NK6 homeobox 3 |
chr6_-_29179584 | 0.54 |
ENSMUST00000159200.1
|
Prrt4
|
proline-rich transmembrane protein 4 |
chr7_+_100607410 | 0.54 |
ENSMUST00000107048.1
ENSMUST00000032946.3 |
Rab6a
|
RAB6A, member RAS oncogene family |
chr4_-_97778042 | 0.53 |
ENSMUST00000146447.1
|
E130114P18Rik
|
RIKEN cDNA E130114P18 gene |
chr17_-_34882004 | 0.52 |
ENSMUST00000152417.1
ENSMUST00000146299.1 |
C2
Gm20547
|
complement component 2 (within H-2S) predicted gene 20547 |
chr5_+_81021202 | 0.52 |
ENSMUST00000117253.1
ENSMUST00000120128.1 |
Lphn3
|
latrophilin 3 |
chr9_+_89909775 | 0.50 |
ENSMUST00000034912.4
ENSMUST00000034909.4 |
Rasgrf1
|
RAS protein-specific guanine nucleotide-releasing factor 1 |
chr5_-_92083667 | 0.50 |
ENSMUST00000113127.3
|
G3bp2
|
GTPase activating protein (SH3 domain) binding protein 2 |
chrX_+_7842056 | 0.50 |
ENSMUST00000115667.3
ENSMUST00000115668.3 ENSMUST00000115665.1 |
Otud5
|
OTU domain containing 5 |
chr5_-_92083455 | 0.50 |
ENSMUST00000169094.1
ENSMUST00000167918.1 |
G3bp2
|
GTPase activating protein (SH3 domain) binding protein 2 |
chr1_+_120340569 | 0.50 |
ENSMUST00000037286.8
|
C1ql2
|
complement component 1, q subcomponent-like 2 |
chr2_-_113217051 | 0.50 |
ENSMUST00000080673.5
|
Ryr3
|
ryanodine receptor 3 |
chr5_-_123141067 | 0.49 |
ENSMUST00000162697.1
ENSMUST00000160321.1 ENSMUST00000159637.1 |
AI480526
|
expressed sequence AI480526 |
chr7_+_100607660 | 0.49 |
ENSMUST00000098252.4
|
Rab6a
|
RAB6A, member RAS oncogene family |
chr9_-_75409951 | 0.49 |
ENSMUST00000049355.10
|
Mapk6
|
mitogen-activated protein kinase 6 |
chr3_+_154664096 | 0.48 |
ENSMUST00000172865.1
|
4922501L14Rik
|
RIKEN cDNA 4922501L14 gene |
chr4_+_32983008 | 0.48 |
ENSMUST00000098190.3
ENSMUST00000029946.7 |
Rragd
|
Ras-related GTP binding D |
chr7_-_141539784 | 0.47 |
ENSMUST00000118694.1
ENSMUST00000153191.1 ENSMUST00000166082.1 ENSMUST00000026586.6 |
Chid1
|
chitinase domain containing 1 |
chr11_+_114851507 | 0.47 |
ENSMUST00000177952.1
|
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr12_-_16800674 | 0.47 |
ENSMUST00000162112.1
|
Greb1
|
gene regulated by estrogen in breast cancer protein |
chr19_+_55898553 | 0.46 |
ENSMUST00000148666.1
|
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chrX_+_69360294 | 0.45 |
ENSMUST00000033532.6
|
Aff2
|
AF4/FMR2 family, member 2 |
chr14_+_118137101 | 0.45 |
ENSMUST00000022728.2
|
Gpr180
|
G protein-coupled receptor 180 |
chr11_+_71749914 | 0.44 |
ENSMUST00000150531.1
|
Wscd1
|
WSC domain containing 1 |
chr9_+_103008479 | 0.44 |
ENSMUST00000035148.6
|
Slco2a1
|
solute carrier organic anion transporter family, member 2a1 |
chr9_-_121759788 | 0.44 |
ENSMUST00000181325.1
|
E530011L22Rik
|
RIKEN cDNA E530011L22 gene |
chr5_+_135168382 | 0.44 |
ENSMUST00000111187.3
ENSMUST00000111188.1 |
Bcl7b
|
B cell CLL/lymphoma 7B |
chrX_+_53607987 | 0.42 |
ENSMUST00000063384.3
ENSMUST00000169626.1 |
Cxx1c
|
CAAX box 1C |
chr14_-_70630149 | 0.42 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr4_-_20778852 | 0.42 |
ENSMUST00000102998.3
|
Nkain3
|
Na+/K+ transporting ATPase interacting 3 |
chrX_+_23693043 | 0.42 |
ENSMUST00000035766.6
ENSMUST00000101670.2 |
Wdr44
|
WD repeat domain 44 |
chrX_+_144688907 | 0.41 |
ENSMUST00000112843.1
|
Zcchc16
|
zinc finger, CCHC domain containing 16 |
chr5_+_135168283 | 0.41 |
ENSMUST00000031692.5
|
Bcl7b
|
B cell CLL/lymphoma 7B |
chr14_-_54994541 | 0.41 |
ENSMUST00000153783.1
ENSMUST00000168485.1 ENSMUST00000102803.3 |
Myh7
|
myosin, heavy polypeptide 7, cardiac muscle, beta |
chr7_+_99535439 | 0.41 |
ENSMUST00000098266.2
ENSMUST00000179755.1 |
Arrb1
|
arrestin, beta 1 |
chr6_+_91684061 | 0.40 |
ENSMUST00000032185.7
|
Slc6a6
|
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
chr7_+_99535652 | 0.40 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr1_+_166254095 | 0.39 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr7_+_31059342 | 0.39 |
ENSMUST00000039775.7
|
Lgi4
|
leucine-rich repeat LGI family, member 4 |
chr2_-_52676571 | 0.38 |
ENSMUST00000178799.1
|
Cacnb4
|
calcium channel, voltage-dependent, beta 4 subunit |
chr6_-_84593810 | 0.38 |
ENSMUST00000077705.3
ENSMUST00000168003.2 |
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1 |
chr10_+_102512216 | 0.38 |
ENSMUST00000055355.4
|
Rassf9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
chr12_+_4234023 | 0.38 |
ENSMUST00000179139.1
|
Ptrhd1
|
peptidyl-tRNA hydrolase domain containing 1 |
chr5_-_74677792 | 0.38 |
ENSMUST00000117525.1
ENSMUST00000153543.1 ENSMUST00000039744.6 ENSMUST00000113531.2 ENSMUST00000121690.1 |
Lnx1
|
ligand of numb-protein X 1 |
chr11_+_100859351 | 0.37 |
ENSMUST00000004145.7
ENSMUST00000133036.1 |
Stat5a
|
signal transducer and activator of transcription 5A |
chr10_+_81628540 | 0.36 |
ENSMUST00000123896.1
|
Ankrd24
|
ankyrin repeat domain 24 |
chr3_-_30509752 | 0.36 |
ENSMUST00000172697.1
|
Mecom
|
MDS1 and EVI1 complex locus |
chr15_+_59315030 | 0.36 |
ENSMUST00000022977.7
|
Sqle
|
squalene epoxidase |
chr2_+_153345809 | 0.36 |
ENSMUST00000109790.1
|
Asxl1
|
additional sex combs like 1 |
chr15_+_59315088 | 0.36 |
ENSMUST00000100640.4
|
Sqle
|
squalene epoxidase |
chr2_+_119237531 | 0.36 |
ENSMUST00000110817.2
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr11_+_95009852 | 0.35 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr2_+_71786923 | 0.35 |
ENSMUST00000112101.1
ENSMUST00000028522.3 |
Itga6
|
integrin alpha 6 |
chr18_+_76059458 | 0.35 |
ENSMUST00000167921.1
|
Zbtb7c
|
zinc finger and BTB domain containing 7C |
chr1_+_87470258 | 0.35 |
ENSMUST00000027476.4
|
3110079O15Rik
|
RIKEN cDNA 3110079O15 gene |
chrX_+_53607918 | 0.35 |
ENSMUST00000114827.1
|
Cxx1c
|
CAAX box 1C |
chr6_-_72788952 | 0.34 |
ENSMUST00000114053.2
|
Tcf7l1
|
transcription factor 7 like 1 (T cell specific, HMG box) |
chr12_-_4233958 | 0.34 |
ENSMUST00000111169.3
ENSMUST00000020981.5 |
Cenpo
|
centromere protein O |
chr15_-_89477400 | 0.34 |
ENSMUST00000165199.1
|
Arsa
|
arylsulfatase A |
chr19_+_6400611 | 0.34 |
ENSMUST00000113467.1
|
Rasgrp2
|
RAS, guanyl releasing protein 2 |
chr14_+_55765956 | 0.34 |
ENSMUST00000057569.3
|
Ltb4r1
|
leukotriene B4 receptor 1 |
chr2_-_172940299 | 0.34 |
ENSMUST00000009143.7
|
Bmp7
|
bone morphogenetic protein 7 |
chr2_+_119237351 | 0.34 |
ENSMUST00000028783.7
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr11_+_100859492 | 0.34 |
ENSMUST00000107356.1
|
Stat5a
|
signal transducer and activator of transcription 5A |
chr2_+_119237453 | 0.33 |
ENSMUST00000110816.1
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr11_+_97799565 | 0.33 |
ENSMUST00000043843.5
|
Lasp1
|
LIM and SH3 protein 1 |
chr3_+_105904377 | 0.33 |
ENSMUST00000000574.1
|
Adora3
|
adenosine A3 receptor |
chr9_+_75410145 | 0.33 |
ENSMUST00000180533.1
ENSMUST00000180574.1 |
4933433G15Rik
|
RIKEN cDNA 4933433G15 gene |
chr18_-_38866702 | 0.33 |
ENSMUST00000115582.1
|
Fgf1
|
fibroblast growth factor 1 |
chr2_+_28840406 | 0.33 |
ENSMUST00000113853.2
|
Ddx31
|
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 |
chr2_-_63184170 | 0.32 |
ENSMUST00000112452.1
|
Kcnh7
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
chr8_-_106136792 | 0.32 |
ENSMUST00000146940.1
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr1_-_9299238 | 0.32 |
ENSMUST00000140295.1
|
Sntg1
|
syntrophin, gamma 1 |
chr4_-_129239165 | 0.32 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr15_+_39745926 | 0.31 |
ENSMUST00000022913.4
|
Dcstamp
|
dentrocyte expressed seven transmembrane protein |
chr8_-_106136890 | 0.31 |
ENSMUST00000115979.2
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr13_+_55369732 | 0.31 |
ENSMUST00000063771.7
|
Rgs14
|
regulator of G-protein signaling 14 |
chr5_-_123140135 | 0.31 |
ENSMUST00000160099.1
|
AI480526
|
expressed sequence AI480526 |
chr4_-_126968124 | 0.31 |
ENSMUST00000106108.2
|
Zmym4
|
zinc finger, MYM-type 4 |
chr16_+_64851991 | 0.31 |
ENSMUST00000067744.7
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr1_+_152399824 | 0.31 |
ENSMUST00000044311.8
|
Colgalt2
|
collagen beta(1-O)galactosyltransferase 2 |
chr13_+_31558157 | 0.31 |
ENSMUST00000042118.8
|
Foxq1
|
forkhead box Q1 |
chr5_+_146231211 | 0.30 |
ENSMUST00000161181.1
ENSMUST00000161652.1 ENSMUST00000031640.8 ENSMUST00000159467.1 |
Cdk8
|
cyclin-dependent kinase 8 |
chr6_+_88724462 | 0.30 |
ENSMUST00000113582.1
|
Mgll
|
monoglyceride lipase |
chr9_+_48495345 | 0.30 |
ENSMUST00000048824.7
|
Gm5617
|
predicted gene 5617 |
chr1_+_59912972 | 0.30 |
ENSMUST00000036540.5
|
Fam117b
|
family with sequence similarity 117, member B |
chr6_-_128826305 | 0.29 |
ENSMUST00000174544.1
ENSMUST00000172887.1 ENSMUST00000032472.4 |
Klrb1b
|
killer cell lectin-like receptor subfamily B member 1B |
chr4_+_117096049 | 0.29 |
ENSMUST00000030443.5
|
Ptch2
|
patched homolog 2 |
chr13_-_94358818 | 0.29 |
ENSMUST00000059598.2
|
Gm9776
|
predicted gene 9776 |
chr9_-_75409352 | 0.29 |
ENSMUST00000168937.1
|
Mapk6
|
mitogen-activated protein kinase 6 |
chr15_+_81936911 | 0.29 |
ENSMUST00000135663.1
|
Csdc2
|
cold shock domain containing C2, RNA binding |
chr8_+_85083269 | 0.29 |
ENSMUST00000034121.9
|
Man2b1
|
mannosidase 2, alpha B1 |
chr10_+_127642975 | 0.28 |
ENSMUST00000092074.5
ENSMUST00000120279.1 |
Stat6
|
signal transducer and activator of transcription 6 |
chr6_+_65671590 | 0.28 |
ENSMUST00000054351.4
|
Ndnf
|
neuron-derived neurotrophic factor |
chr17_+_78508063 | 0.28 |
ENSMUST00000024880.9
|
Vit
|
vitrin |
chr7_+_43634718 | 0.28 |
ENSMUST00000032663.8
|
Ceacam18
|
carcinoembryonic antigen-related cell adhesion molecule 18 |
chr12_+_61523889 | 0.27 |
ENSMUST00000119481.1
ENSMUST00000055815.7 |
Lrfn5
|
leucine rich repeat and fibronectin type III domain containing 5 |
chr10_-_127751707 | 0.27 |
ENSMUST00000079692.5
|
Gpr182
|
G protein-coupled receptor 182 |
chr12_+_17690793 | 0.27 |
ENSMUST00000071858.3
|
Hpcal1
|
hippocalcin-like 1 |
chr9_-_87731248 | 0.27 |
ENSMUST00000034991.7
|
Tbx18
|
T-box18 |
chr6_-_142964404 | 0.27 |
ENSMUST00000032421.3
|
St8sia1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
chr6_+_88724828 | 0.27 |
ENSMUST00000089449.2
|
Mgll
|
monoglyceride lipase |
chr10_-_117845935 | 0.27 |
ENSMUST00000064667.7
|
Rap1b
|
RAS related protein 1b |
chr7_+_144896523 | 0.26 |
ENSMUST00000033389.5
|
Fgf15
|
fibroblast growth factor 15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 1.9 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.4 | 1.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.4 | 1.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.3 | 1.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 1.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.3 | 1.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 1.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 2.5 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) |
0.2 | 0.7 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 0.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.2 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.2 | 0.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 1.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.6 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 0.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 1.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.1 | 0.4 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.1 | 0.4 | GO:1902809 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) cornification(GO:0070268) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.3 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.3 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.1 | 0.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 1.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 1.5 | GO:0015812 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.1 | 0.2 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.1 | 0.6 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.1 | 0.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.9 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.2 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) negative regulation of apoptotic cell clearance(GO:2000426) |
0.1 | 2.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.6 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.1 | 1.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 1.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.7 | GO:0019370 | glutathione biosynthetic process(GO:0006750) leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.5 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.3 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.1 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.0 | 0.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.0 | 0.2 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.0 | 0.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.0 | 0.2 | GO:1903278 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.0 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.0 | 1.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 1.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
0.0 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0071879 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.0 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0001802 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.9 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 1.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.0 | 0.1 | GO:1903225 | tendon development(GO:0035989) negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 1.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 1.9 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 1.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 1.2 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.3 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.5 | 1.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 1.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 1.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.0 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 1.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 1.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 1.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.4 | 1.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 1.1 | GO:0005118 | sevenless binding(GO:0005118) |
0.3 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 0.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 1.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 0.7 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 0.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.4 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
0.1 | 0.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.1 | 1.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0030977 | taurine binding(GO:0030977) |
0.1 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.6 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 2.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.6 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 1.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 1.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 1.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.9 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 2.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 1.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 1.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 2.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 3.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 2.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 2.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 3.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |